- Home
- PBYI vs LFVN Comparison
PBYI vs LFVN Comparison
Compare PBYI & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- LFVN
- Stock Information
- Founded
- PBYI 2010
- LFVN N/A
- Country
- PBYI United States
- LFVN United States
- Employees
- PBYI N/A
- LFVN N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- PBYI Health Care
- LFVN Health Care
- Exchange
- PBYI Nasdaq
- LFVN Nasdaq
- Market Cap
- PBYI 171.7M
- LFVN 165.9M
- IPO Year
- PBYI N/A
- LFVN N/A
- Fundamental
- Price
- PBYI $3.28
- LFVN $13.71
- Analyst Decision
- PBYI Strong Buy
- LFVN Strong Buy
- Analyst Count
- PBYI 1
- LFVN 2
- Target Price
- PBYI $7.00
- LFVN $30.50
- AVG Volume (30 Days)
- PBYI 351.2K
- LFVN 226.6K
- Earning Date
- PBYI 08-07-2025
- LFVN 08-27-2025
- Dividend Yield
- PBYI N/A
- LFVN 1.17%
- EPS Growth
- PBYI 143.51
- LFVN 152.87
- EPS
- PBYI 0.77
- LFVN 0.70
- Revenue
- PBYI $232,709,000.00
- LFVN $222,347,000.00
- Revenue This Year
- PBYI N/A
- LFVN $17.36
- Revenue Next Year
- PBYI N/A
- LFVN $9.60
- P/E Ratio
- PBYI $4.25
- LFVN $19.57
- Revenue Growth
- PBYI 2.68
- LFVN 8.22
- 52 Week Low
- PBYI $2.23
- LFVN $6.76
- 52 Week High
- PBYI $4.13
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- PBYI 40.98
- LFVN 56.88
- Support Level
- PBYI $3.34
- LFVN $12.03
- Resistance Level
- PBYI $3.55
- LFVN $14.91
- Average True Range (ATR)
- PBYI 0.13
- LFVN 0.88
- MACD
- PBYI -0.02
- LFVN 0.10
- Stochastic Oscillator
- PBYI 11.11
- LFVN 62.03
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.